Position in FNCHQ
as of Mar 31, 2024
· filed May 10, 2024
Position Value
$850
-$380 QoQ
Shares Held
327
-4.1% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FNCHQ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2024BlackRock Inc. holds $54,091,702,062 across 441 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
21,312,244 | $9,989,474,999 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
8,446,366 | $8,877,384,047 | |
| 3 | MRNA |
Moderna, Inc.
|
25,562,321 | $3,035,525,609 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,547,663 | $2,320,082,109 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
22,738,349 | $1,872,048,264 | |
| 6 | SRPT |
Sarepta Therapeutics, Inc.
|
10,324,404 | $1,631,255,832 | |
| 7 | INCY |
Incyte Corp
|
21,356,274 | $1,294,617,319 | |
| 8 | TECH |
BIO-TECHNE Corp
|
14,987,870 | $1,073,880,877 |
All Filings in FNCHQ
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2024-03-31 | $850 | 327 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,230 | 341 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,766 | 341 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,908 | 341 | Shares | Sole | 2023-08-11 | |
| No filing history on record for this holder in this stock. | ||||||